NDV-01 is a novel, sustained-release, intravesical gemcitabine/docetaxel, ready-for-use product candidate for the treatment of non-muscle ...

Charles Schwab Investment Management Inc. increased its position in shares of GeneDx Holdings Corp. (NASDAQ:WGS – Free Report ...

GeneDx , a leader in delivering improved health outcomes through genomic insights, announced today they have been named to Fast Company's prestigious list of the World's Most Innovative Companies of ...

BTIG analyst Mark Massaro maintained a Buy rating on GeneDx Holdings (WGS – Research Report) yesterday and set a price target of $115.00. The ...

VolitionRx Limited ("Volition"), a multi-national epigenetics company, today announced the expansion of its Nu.Q® Vet Cancer Test supply agreement (the "Agreement") with Fujifilm Vet Systems Co. Ltd ( ...

A public beta for iOS 19 will likely be released in July, followed by a release to everyone in September. Do you have any features on your iOS 19 wishlist? Are you hoping that Apple continues to ...

While nothing is confirmed at the moment, from release timeline to second trailer, here’s everything we know so far about GTA 6. Earlier this year, Rockstar Games’ parent company – Take-Two ...

All products and promotions are independently selected by our experts. To help us provide free impartial advice, we will earn an affiliate commission if you buy something. Click here to learn more ...

In this article, we are going to take a look at where GeneDx Holdings Corp. (NASDAQ:WGS) stands against the other emerging technology stocks. The technology sector is constantly evolving ...

We recently compiled a list of the 10 Best Emerging Technology Stocks to Buy Now. In this article, we are going to take a look at where GeneDx Holdings Corp. (NASDAQ:WGS) stands against the other ...